CORGENTIN Trademark

Trademark Overview

On Monday, September 17, 2007, a trademark application was filed for CORGENTIN with the United States Patent and Trademark Office. The USPTO has given the CORGENTIN trademark a serial number of 77281516. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 14, 2010. This trademark is owned by Cardium Therapeutics, Inc.. The CORGENTIN trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceuticals; cardiovascular biologics; pharmaceutical products and preparations comprising DNA or protein for use in the treatment of cardiovascular disease
corgentin

General Information

Serial Number77281516
Word MarkCORGENTIN
Filing DateMonday, September 17, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 14, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2008

Trademark Statements

Goods and ServicesCardiovascular pharmaceuticals; cardiovascular biologics; pharmaceutical products and preparations comprising DNA or protein for use in the treatment of cardiovascular disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 20, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCardium Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameCardium Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, June 14, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 14, 2010ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 6, 2010EXTENSION 2 GRANTED
Wednesday, November 11, 2009EXTENSION 2 FILED
Wednesday, December 16, 2009EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, December 16, 2009PETITION TO REVIVE-GRANTED
Wednesday, December 16, 2009TEAS PETITION TO REVIVE RECEIVED
Monday, December 14, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 14, 2009ABANDONMENT - NO USE STATEMENT FILED
Monday, July 6, 2009EXTENSION 1 GRANTED
Monday, May 11, 2009EXTENSION 1 FILED
Monday, July 6, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 8, 2009PAPER RECEIVED
Wednesday, June 3, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 3, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 18, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 19, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 12, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 11, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2008NOTICE OF PUBLICATION
Thursday, July 17, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 15, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 14, 2008AMENDMENT FROM APPLICANT ENTERED
Monday, July 14, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 14, 2008ASSIGNED TO LIE
Friday, July 11, 2008PAPER RECEIVED
Friday, December 21, 2007NON-FINAL ACTION MAILED
Friday, December 21, 2007NON-FINAL ACTION WRITTEN
Wednesday, December 19, 2007ASSIGNED TO EXAMINER
Thursday, September 20, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

corgentin cardiovascular protein treatment disease comprising products pharmaceuticals biologics pharmaceutical preparations